Clinical Trial Update: Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating ketamine as an adjunct therapy for acute vaso-occlusive crisis in pediatric patients with sickle …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Augusta University | Conditions: Sickle Cell Disease | Phase 3 | Status: UNKNOWN